Martin Plambech

Martin Plambech

Martin Plambech, CEO of Biosyntia

Martin Plambech is the CEO of Biosyntia, which develops novel fermentation processes. Prior to Biosyntia, he was responsible for business development within Animal Health & Nutrition, Novozymes. He has also worked for Boston Consulting Group in Europe & Australia and been a First Lieutenant in the Danish Army. He holds a M.Sc. in Finance & Strategic Management from Copenhagen Business School.
2018-09-09T02:53:04+00:00